COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03225989
Recruitment Status : Recruiting
First Posted : July 21, 2017
Last Update Posted : February 25, 2020
Uppsala University
Information provided by (Responsible Party):
Lokon Pharma AB

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : December 1, 2022